2927 — AFC-HD AMS Life Science Co Cashflow Statement
0.000.00%
Last trade - 00:00
- ¥12bn
- ¥23bn
- ¥26bn
- 29
- 88
- 66
- 69
2019 August 31st | 2020 August 31st | 2021 August 31st | 2022 August 31st | 2023 August 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 1,091 | 1,004 | 2,158 | 1,235 | 1,546 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | -65.4 | 149 | 64 | -238 | 102 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -367 | -364 | -288 | -512 | -1,767 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accounts Payable | |||||
Change in Taxes Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 1,132 | 1,299 | 2,583 | 1,492 | 865 |
Capital Expenditures | -547 | -381 | -492 | -958 | -1,940 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 345 | -77.5 | 217 | -120 | -6.33 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -202 | -459 | -275 | -1,078 | -1,946 |
Financing Cash Flow Items | -95.7 | -93.8 | -58.8 | -584 | -52.7 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -547 | -575 | 2,185 | 1,160 | 1,881 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 378 | 268 | 4,496 | 1,591 | 804 |